Selenium and the thyroid

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 22, Issue 5, 2015, Pages 392-401

  Köhrle, Josef ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

autoimmune disease; goiter; selenoprotein; thyroid cancer; thyroiditis; trace element

Indexed keywords

BIOLOGICAL MARKER; SELENIUM; SELENOPROTEIN; THIOREDOXIN REDUCTASE; THYROID HORMONE; SELENOPROTEIN P;

AGING; AUTOIMMUNE DISEASE; BIOSYNTHESIS; CONGENITAL HYPOTHYROIDISM; GENE INACTIVATION; HUMAN; IRON INTAKE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; SUPPLEMENTATION; THYROID DISEASE; THYROID FUNCTION; THYROID GLAND; THYROID GLAND TISSUE; THYROID HORMONE METABOLISM; METABOLISM; NUTRITIONAL STATUS; PHYSIOLOGY;

HUMANS; NUTRITIONAL STATUS; SELENIUM; SELENOPROTEIN P; THYROID DISEASES; THYROID GLAND;

EID: 84960096559     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000190     Document Type: Review

References (143)

1. Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol 2015; 3:286-295.
2. Li M, Eastman CJ. The changing epidemiology of iodine deficiency. Nat Rev Endocrinol 2012; 8:434-440.
3. Meisinger C, Ittermann T, Wallaschofski H, et al. Geographic variations in the frequency of thyroid disorders and thyroid peroxidase antibodies in persons without former thyroid disease within Germany. Eur J Endocrinol 2012; 167:363-371.
4. Ittermann T, Khattak RM, Nauck M, et al. Shift of the TSH reference range with improved iodine supply in Northeast Germany. Eur J Endocrinol 2015; 172:261-267.
5. Köhrle J. Pathophysiological relevance of selenium. J Endocrinol Invest 2013; 36 (Suppl 10):1-7.
6. Schomburg L, Köhrle J. On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Mol Nutr Food Res 2008; 52:1235-1246.
7. Köhrle J, Jakob F, Contempre B, Dumont JE. Selenium, the thyroid, and the endocrine system. Endocr Rev 2005; 26:944-984.
8. Contempre B, Le Moine O, Dumont JE, et al. Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor beta (TGF-beta). Mol Cell Endocrinol 1996; 124:7-15.
9. Contempre B, Dumont JE, Denef JF, Many MC. Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism. Eur J Endocrinol 1995; 133:99-109.
10. Liu Y, Huang H, Zeng J, Sun C. Thyroid volume, goiter prevalence, and selenium levels in an iodine-sufficient area: a cross-sectional study. BMC Public Health 2013; 13:1153.
11. Knudsen N, Brix TH.Genetic and noniodine-related factors in the aetiology of nodular goitre Best Pract Res Clin Endocrinol Metab 2014 28 495-506.
12. Hess SY. The impact of common micronutrient deficiencies on iodine and thyroid metabolism: the evidence from human studies. Best Pract Res Clin Endocrinol Metab 2010; 24:117-132.
13. Zimmermann MB. The influence of iron status on iodine utilization and thyroid function. Annu Rev Nutr 2006; 26:367-389.
14. Yu X, Shan Z, Li C, et al. Iron deficiency, an independent risk factor for isolated hypothyroxinemia in pregnant and nonpregnant women of childbearing age in China. J Clin Endocrinol Metab 2015; 100:1594-1601.
15. Jain RB, Choi YS. Interacting effects of selected trace and toxic metals on thyroid function. Int J Environ Health Res 2015. [Epub ahead of print]
16. Jain RB. Thyroid function and serum copper, selenium, and zinc in general U.S. population. Biol Trace Elem Res 2014; 159:87-98.
17. Cooper R, Pinkney J, Ayling RM. Appropriateness of prescribing thyroxine in primary care. Ann Clin Biochem 2015; 52 (Pt 4):497-501.
18. Biron VL, Bang H, Farwell DG, Bewley AF. National trends and factors associated with hospital costs following thyroid surgery. Thyroid 2015; 25:823-829.
19. Nexo MA, Watt T, Pedersen J, et al. Increased risk of long-Term sickness absence, lower rate of return to work, and higher risk of unemployment and disability pensioning for thyroid patients: a Danish register-based cohort study. J Clin Endocrinol Metab 2014; 99:3184-3192.
20. IMS Institute for Healthcare Informatics Medicine use and shifting costs of healthcare: a review of the use of medicines in the United States in 2013.
21. Glaeske G, Schicktanz C. Arzneimittel report 2012 (short version: http:// www.zes.uni-bremen.de/uploads/News/2012/120829-Kurzfassung-AMReport. pdf). [Accessed 23 July 2015].
22. Stagnaro-Green A. Screening pregnant women for overt thyroid disease. J Am Med Assoc 2015; 313:565-566.
23. Contempre B, Duale NL, Dumont JE, et al. Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clin Endocrinol (Oxf) 1992; 36:579-583.
24. Xu J, Liu XL, Yang XF, et al. Supplemental selenium alleviates the toxic effects of excessive iodine on thyroid. Biol Trace Elem Res 2011; 141:110-118.
25. Köhrle J, Gärtner R. Selenium and thyroid. Best Pract Res Clin Endocrinol Metab 2009; 23:815-827.
26. Wiersinga WM. Thyroid autoimmunity. Endocr Dev 2014; 26:139-157.
27. Luo Y, Kawashima A, Ishido Y, et al. Iodine excess as an environmental risk factor for autoimmune thyroid disease. Int J Mol Sci 2014; 15:12895-12912.
28. Prete A, Paragliola RM, Corsello SM. Iodine supplementation: usage ?with a grain of salt?. Int J Endocrinol 2015; 2015:312305.
29. Leung AM, Braverman LE. Consequences of excess iodine. Nat Rev Endocrinol 2014; 10:136-142.
30. Ma ZF, Skeaff SA. Thyroglobulin as a biomarker of iodine deficiency: a review. Thyroid 2014; 24:1195-1209.
31. Chiu-Ugalde J, Wirth EK, Klein MO, et al. Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells. Antioxid Redox Signal 2012; 17:902-913.
32. Duntas LH, Benvenga S. Selenium: an element for life. Endocrine 2015; 48:756-775.
33. Burk RF, Hill KE. Regulation of selenium metabolism and transport. Annu Rev Nutr 17; 35:109-134.
34. Ashton K,Hooper L,Harvey LJ, et al.Methods of assessment of seleniumstatus in humans: a systematic review Am J Clin Nutr 2009 89 2025S-2039S.
35. Ralston NV, Raymond LJ. Dietary selenium?s protective effects against methylmercury toxicity. Toxicology 2010; 278:112-123.
36. Schmutzler C, Mentrup B, Schomburg L, et al. Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol Chem 2007; 388:1053-1059.
37. Schweizer U, Chiu J, Köhrle J. Peroxides and peroxide-Degrading enzymes in the thyroid. Antioxid Redox Signal 2008; 10:1577-1592.
38. Schomburg L. Selenium, selenoproteins and the thyroid gland: interactions in health and disease. Nat Rev Endocrinol 2011; 8:160-171.
39. Fairweather-Tait SJ, Bao Y, Broadley MR, et al. Selenium in human health and disease. Antioxid Redox Signal 2011; 14:1337-1383.
40. Renko K, Hofmann PJ, Stoedter M, et al. Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice. FASEB J 2009; 23:1758-1765.
41. Schomburg L, Schweizer U, Holtmann B, et al. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J 2003; 370 (Pt 2):397-402.
42. Burk RF, Hill KE, Motley AK, et al. Deletion of selenoprotein P upregulates urinary selenium excretion and depresses whole-body selenium content. Biochim Biophys Acta 2006; 1760:1789-1793.
43. Olson GE, Winfrey VP, Nagdas SK, et al. Apolipoprotein E receptor-2 (ApoER2) mediates selenium uptake from selenoprotein P by the mouse testis. J Biol Chem 2007; 282:12290-12297.
44. Schweizer U, Dehina N, Schomburg L. Disorders of selenium metabolism and selenoprotein function. Curr Opin Pediatr 2011; 23:429-435.
45. Burk RF, Hill KE, Motley AK, et al. Selenoprotein P and apolipoprotein E receptor-2 interact at the blood-brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration. FASEB J 2014; 28:3579-3588.
46. Schweizer U, Weitzel JM, Schomburg L. Think globally: act locally. New insights into the local regulation of thyroid hormone availability challenge long accepted dogmas. Mol Cell Endocrinol 2008; 289:1-9.
47. Schomburg L, Riese C, Michaelis M, et al. Synthesis and metabolism of thyroid hormones is preferentially maintained in selenium-Deficient transgenic mice. Endocrinology 2006; 147:1306-1313.
48. Burk RF, Olson GE, Hill KE, et al. Maternal-fetal transfer of selenium in the mouse. FASEB J 2013; 27:3249-3256.
49. Fu J,DumitrescuAM. Inheriteddefects in thyroid hormone cell-membrane transport and metabolism. Best Pract Res Clin Endocrinol Metab 2014; 28:189-201.
50. Dumitrescu AM, Liao XH, Abdullah MS, et al. Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet 2005; 37:1247-1252.
51. Azevedo MF, Barra GB, Naves LA, et al. Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J Clin Endocrinol Metab 2010; 95:4066-4071.
52. Schoenmakers E, Agostini M, Mitchell C, et al. Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J Clin Invest 2010; 120:4220-4235.
53. Hamajima T, Mushimoto Y, Kobayashi H, et al. Novel compound heterozygous mutations in the SBP2 gene: characteristic clinical manifestations and the implications of GH and triiodothyronine in longitudinal bone growth and maturation. Eur J Endocrinol 2012; 166:757-764.
54. Schomburg L, Dumitrescu AM, Liao XH, et al. Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations. Thyroid 2009; 19:277-281.
55. Seeher S, Atassi T, Mahdi Y, et al. Secisbp2 is essential for embryonic development and enhances selenoprotein expression. Antioxid Redox Signal 2014; 21:835-849.
56. Conrad M, Schweizer U. Unveiling the molecular mechanisms behind selenium-related diseases through knockout mouse studies. Antioxid Redox Signal 2010; 12:851-865.
57. Castets P, Lescure A, Guicheney P, Allamand V. Selenoprotein N in skeletal muscle: from diseases to function. J Mol Med (Berl) 2012; 90:1095-1107.
58. Jørgensen JO, Møller J, Laursen T, et al. Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-Dependent manner and suppresses circadian thyrotrophin levels: studies in GH-Deficient adults. Clin Endocrinol (Oxf) 1994; 41:609-614.
59. Portes ES, Oliveira JH, MacCagnan P, Abucham J. Changes in serum thyroid hormones levels and their mechanisms during long-Term growth hormone (GH) replacement therapy in GH deficient children. Clin Endocrinol (Oxf) 2000; 53:183-189.
60. Kalina-Faska B, Kalina M, Koehler B. Effects of recombinant growth hormone therapy on thyroid hormone concentrations. Int J Clin Pharmacol Ther 2004; 42:30-34.
61. Gross M, Oertel M, Köhrle J. Differential selenium-Dependent expression of type I 5?-Deiodinase and glutathione peroxidase in the porcine epithelial kidney cell line LLC-PK1. Biochem J 1995; 306 (Pt 3):851-856.
62. Behne D, Kyriakopoulos A, Meinhold H, Köhrle J. Identification of type I iodothyronine 5?-Deiodinase as a selenoenzyme. Biochem Biophys Res Commun 1990; 173:1143-1149.
63. Arthur JR, Nicol F, Beckett GJ. Hepatic iodothyronine 5?-Deiodinase. The role of selenium. Biochem J 1990; 272:537-540.
64. Berry MJ, Banu L, Chen YY, et al. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3? untranslated region. Nature 1991; 353:273-276.
65. Humann-Ziehank E, Renko K, Mueller AS, et al. Comparing functional metabolic effects of marginal and sufficient selenium supply in sheep. J Trace Elem Med Biol 2013; 27:380-390.
66. Guyot H, de Oliveira LA, Ramery E, et al. Effect of a combined iodine and selenium supplementation on I and Se status of cows and their calves. J Trace Elem Med Biol 2011; 25:118-124.
67. Gereben B, Zavacki AM, Ribich S, et al. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 2008; 29:898-938.
68. Labunskyy VM, Hatfield DL, Gladyshev VN. Selenoproteins: molecular pathways and physiological roles. Physiol Rev 2014; 94:739-777.
69. Pillai R, Uyehara-Lock JH, Bellinger FP. Selenium and selenoprotein function in brain disorders. IUBMB Life 2014; 66:229-239.
70. Hatfield DL, Tsuji PA, Carlson BA, Gladyshev VN. Selenium and selenocysteine: roles in cancer, health, and development. Trends Biochem Sci 2014; 39:112-120.
71. Roman M, Jitaru P, Barbante C. Selenium biochemistry and its role for human health. Metallomics 2014; 6:25-54.
72. Contempre B, de Escobar GM, Denef JF, et al. Thiocyanate induces cell necrosis and fibrosis in selenium-And iodine-Deficient rat thyroids: a potential experimental model for myxedematous endemic cretinism in central Africa. Endocrinology 2004; 145:994-1002.
73. Golstein J, Corvilain B, Lamy F, et al. Effects of a selenium deficient diet on thyroid function of normal and perchlorate treated rats. Acta Endocrinol (Copenh) 1988; 118:495-502.
74. Shchedrina VA, Zhang Y, Labunskyy VM, et al. Structure-function relations, physiological roles, and evolution of mammalian ER-resident selenoproteins. Antioxid Redox Signal 2010; 12:839-849.
75. Turanov AA, Shchedrina VA, Everley RA, et al. Selenoprotein S is involved in maintenance and transport of multiprotein complexes. Biochem J 2014; 462:555-565.
76. Bhowmick D, Srivastava S, D?Silva P, Mugesh G. Highly efficient glutathione peroxidase and peroxiredoxin mimetics protect mammalian cells against oxidative damage. Angew Chem Int Ed Engl 2015; 54:8449-8453.
77. Raja K, Mugesh G. Remarkable effect of chalcogen substitution on an enzyme mimetic for deiodination of thyroid hormones. Angew Chem Int Ed Engl 2015; 54:7674-7678.
78. Manna D, Roy G, Mugesh G. Antithyroid drugs and their analogues: synthesis, structure, and mechanism of action. Acc Chem Res 2013; 46:2706-2715.
79. Rijntjes E, Scholz PM, Mugesh G, Köhrle J. Se-And S-based thiouracil and methimazole analogues exert different inhibitory mechanisms on type 1 and type 2 deiodinases. Eur Thyroid J 2013; 2:252-258.
80. Weissel M. Propylthiouracil: clinical overview of its efficacy and its side effects more than 50 years after the introduction of its use in thyrostatic treatment. Exp Clin Endocrinol Diabetes 2010; 118:101-104.
81. Gershengorn MC, Neumann S. Update in TSH receptor agonists and antagonists. J Clin Endocrinol Metab 2012; 97:4287-4292.
82. Derumeaux H, Valeix P, Castetbon K, et al. Association of selenium with thyroid volume and echostructure in 35-to 60-year-old French adults. Eur J Endocrinol 2003; 148:309-315.
83. Rasmussen LB, Schomburg L, Köhrle J, et al. Selenium status, thyroid volume, and multiple nodule formation in an area with mild iodine deficiency. Eur J Endocrinol 2011; 164:585-590.
84. Bülow Pedersen I, Knudsen N, Carle A, et al. Serum selenium is low in newly diagnosed Graves? disease. A population based study. Clin Endocrinol (Oxf) 2013; 79:584-590.
85. van Zuuren EJ, Albusta AY, Fedorowicz Z, et al. Selenium supplementation for Hashimoto?s thyroiditis. Cochrane Database Syst Rev 2013; 6:CD010223.
86. Vanderpump MP. The epidemiology of thyroid disease. Br Med Bull 2011; 99:39-51.
87. Bauer M, Glenn T, Pilhatsch M, et al. Gender differences in thyroid system function: relevance to bipolar disorder and its treatment. Bipolar Disord 2014; 16:58-71.
88. Vannucchi G, De Leo S, Perrino M, et al. Impact of estrogen and progesterone receptor expression on the clinical and molecular features of papillary thyroid cancer. Eur J Endocrinol 2015; 173:29-36.
89. Simmonds MJ, Kavvoura FK, Brand OJ, et al. Skewed X chromosome inactivation and female preponderance in autoimmune thyroid disease: an association study and meta-Analysis. J Clin Endocrinol Metab 2014; 99:E127-E131.
90. Li H, Li J. Thyroid disorders in women. Minerva Med 2015; 106:109-114.
91. Effraimidis G, Wiersinga WM. Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol 2014; 170:R241-R252.
92. Riese C, Michaelis M, Mentrup B, et al. Selenium-Dependent pre and posttranscriptional mechanisms are responsible for sexual dimorphic expression of selenoproteins in murine tissues. Endocrinology 2006; 147:5883-5892.
93. Stoedter M, Renko K, Ho?g A, Schomburg L. Selenium controls the sexspecific immune response and selenoprotein expression during the acutephase response in mice. Biochem J 2010; 429:43-51.
94. Combs GF Jr, Midthune DN, Patterson KY, et al. Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in healthy adults. Am J Clin Nutr 2009; 89:1808-1814.
95. Schomburg L, Schweizer U. Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochim Biophys Acta 2009; 1790:1453-1462.
96. Glattre E, Nygård JF, Aaseth J. Selenium and cancer prevention: observations and complexity. J Trace Elem Med Biol 2012; 26:168-169.
97. ColonnaM, Uhry Z, Guizard A, et al. Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France. Cancer Epidemiol 2015; 2015 May 20. pii: S1877-7821(15)00097-1. [Epub ahead of print]
98. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 2014; 140:317-322.
99. Pellegriti G, Frasca F, Regalbuto C, et al. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013; 2013:965212.
100. Davis CD, Tsuji PA, Milner JA. Selenoproteins and cancer prevention. Annu Rev Nutr 2012; 32:73-95.
101. Rayman MP. Selenium and human health. Lancet 2012; 379:1256-1268.
102. Moncayo R, Kroiss A, Oberwinkler M, et al. The role of selenium, vitamin C, and zinc in benign thyroid diseases and of selenium in malignant thyroid diseases: low selenium levels are found in subacute and silent thyroiditis and in papillary and follicular carcinoma. BMC Endocr Disord 2008; 8:2.
103. Shen F, Cai WS, Li JL, et al. The association between serum levels of selenium, copper, and magnesium with thyroid cancer: a meta-Analysis. Biol Trace Elem Res 2015. [Epub ahead of print] Review on role and interaction between trace elements in thyroid cancer and discussion of regional differences possibly related to ethnic or environmental factors.
104. Ren Y, Kitahara CM, Berrington de Gonzalez A, et al. Lack of association between fingernail selenium and thyroid cancer risk: a case-control study in French Polynesia. Asian Pac J Cancer Prev 2014; 15:5187-5194.
105. O?Grady TJ, Kitahara CM, DiRienzo AG, Gates MA. The association between selenium and other micronutrients and thyroid cancer incidence in the NIHAARP Diet and Health Study. PLoS One 2014; 9:e110886.
106. Przybylik-Mazurek E, Zagrodzki P, Kuzniarz-Rymarz S, Hubalewska-Dydejczyk A. Thyroid disorders-Assessments of trace elements, clinical, and laboratory parameters. Biol Trace Elem Res 2011; 141:65-75.
107. Hesse-Bähr K, Dreher I, Köhrle J. The influence of the cytokines Il-1beta and INFgamma on the expression of selenoproteins in the human hepatocarcinoma cell line HepG2. Biofactors 2000; 11:83-85.
108. Dreher I, Jakobs TC, Köhrle J. Cloning and characterization of the human selenoprotein P promoter. Response of selenoprotein P expression to cytokines in liver cells. J Biol Chem 1997; 272:29364-29371.
109. Becker NP, Martitz J, Renko K, et al. Hypoxia reduces and redirects selenoprotein biosynthesis. Metallomics 2014; 6:1079-1086.
110. Hotz CS, Fitzpatrick DW, Trick KD, L?Abbe MR. Dietary Iodine and selenium interact to affect thyroid hormone metabolism of rats. J Nutr 1997; 127:1214-1218.
111. Rasmussen LB, Hollenbach. Laurberg P, et al. Serum selenium and selenoprotein P status in adult Danes-8-year followup. J Trace Elem Med Biol 2009; 23:265-271.
112. Brauer VF, Schweizer U, Köhrle J, Paschke R. Selenium and goiter prevalence in borderline iodine sufficiency. Eur J Endocrinol 2006; 155:807-812.
113. Mao J, Pop VJ, Bath SC, et al. Effect of low-Dose selenium on thyroid autoimmunity and thyroid function in UK pregnant women with mild-Tomoderate iodine deficiency. Eur J Nutr 2014. [Epub ahead of print] No effect of selenium supplementation on TPO antibody titers but on thyroid function was observed; dose might have been too low and follow-up of postpartum thyroid function has not been studied in detail.
114. Koukkou E, Ilias I, Alexiou M, et al. Urine selenium changes during pregnancy do not correlate with thyroid autoantibodies in a mildly iodine deficient population. Biol Trace Elem Res 2014; 157:9-13.
115. Xue H, Wang W, Li Y, et al. Selenium upregulates CD4(+)CD25(+) regulatory T cells in iodine-induced autoimmune thyroiditis model of NOD.H-2(h4) mice. Endocr J 2010; 57:595-601.
116. Huang Z, Rose AH, Hoffmann PR. The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2012; 16:705-743.
117. Tan L, Sang ZN, Shen J, et al. Selenium supplementation alleviates autoimmune thyroiditis by regulating expression of TH1/TH2 cytokines. Biomed Environ Sci 2013; 26:920-925.
118. Hawkes WC, Richter D, Alkan Z. Dietary selenium supplementation and whole blood gene expression in healthy North American men. Biol Trace Elem Res 2013; 155:201-208.
119. Toulis KA, Anastasilakis AD, Tzellos TG, et al. Selenium supplementation in the treatment of Hashimoto?s thyroiditis: a systematic review and a metaanalysis. Thyroid 2010; 20:1163-1173.
120. Drutel A, Archambeaud F, Caron P. Selenium and the thyroid gland. More Good News for Clinicians. Clin Endocrinol 2013; 78:155-164.
121. Negro R, Greco G, Mangieri T, et al. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007; 92:1263-1268.
122. Rayman MP, Thompson AJ, Bekaert B, et al. Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom. Am J Clin Nutr 2008; 87:370-378.
123. Eskes SA, Endert E, Fliers E, et al. Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies. Clin Endocrinol (Oxf) 2014; 80:444-451.
124. Marcocci C, Kahaly GJ, Krassas GE, et al., European Group on Graves Orbitopathy. Selenium and the course of mild Graves? orbitopathy. N Engl J Med 2011; 364:1920-1931.
125. Watt T, Cramon P, Bjorner JB, et al. Selenium supplementation for patients with Graves? hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial. Trials 2013; 14:119.
126. Winther KH, Watt T, Bjørner JB, et al. The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial. Trials 2014; 15:115.
127. Burk RF, Hill KE, Selenoprotein P. an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 2005; 25:215-235.
128. Burk RF, Norsworthy BK, Hill KE, et al. Effects of chemical form of selenium on plasma biomarkers in a high-Dose human supplementation trial. Cancer Epidemiol Biomarkers Prev 2006; 15:804-810.
129. Hollenbach B, Morgenthaler NG, Struck J, et al. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol 2008; 22:24-32.
130. Hoeflich J, Hollenbach B, Behrends T, et al. The choice of biomarkers determines the selenium status in young German vegans and vegetarians. Br J Nutr 2010; 104:1601-1604.
131. Combs GF Jr, Watts JC, Jackson MI, et al. Determinants of selenium status in healthy adults. Nutr J 2011; 10:75.
132. Xia Y, Hill KE, Li P, et al. Optimization of selenoprotein P and other plasma seleniumbiomarkers for theassessment of theseleniumnutritionalrequirement: a placebo-controlled, double-blind study of selenomethionine supplementation in selenium-Deficient Chinese subjects. Am J Clin Nutr 2010; 92:525-531.
133. Hurst R, Collings R, Harvey LJ, et al. EURRECA-Estimating selenium requirements for deriving dietary reference values. Crit Rev Food Sci Nutr 2013; 53:1077-1096.
134. Hurst R, Armah CN, Dainty JR, et al. Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2010; 91:923-931.
135. Combs Jr. G.F. Biomarkers of selenium status. Nutrients 2015; 7:2209-2236.
136. White L, Romagne F, Müller E, et al. Genetic adaptation to levels of dietary selenium in recent human history. Mol Biol Evol 2015; 32:1507-1518.
137. Hargreaves MK, Liu J, Buchowski MS, et al. Plasma selenium biomarkers in low income black and white Americans from the southeastern United States. PLoS One 2014; 9:e84972.
138. Epplein M, Burk RF, CaiQ, et al. A prospective study of plasma selenoprotein P and lung cancer risk among low-income adults. Cancer Epidemiol Biomarkers Prev 2014; 23:1238-1244.
139. Hellwege JN, Palmer ND, Ziegler JT, et al. Genetic variants in selenoprotein P plasma 1 gene (SEPP1) are associated with fasting insulin and first phase insulin response in Hispanics. Gene 2014; 534:33-39.
140. Köhrle J. Environment and endocrinology: the case of thyroidology. Ann Endocrinol (Paris) 2008; 69:116-122.
141. Leung AM, Pearce EN, Braverman LE. Environmental perchlorate exposure: potential adverse thyroid effects. Curr Opin Endocrinol Diabetes Obes 2014; 21:372-376.
142. Council on Environmental Health. Rogan WJ, Paulson JA, Baum C, et al. Iodine deficiency, pollutant chemicals, and the thyroid: new information on an old problem. Pediatrics 2014; 133:1163-1166.
143. Romagne F, Santesmasses D, White L, et al. SelenoDB 2.0: annotation of selenoprotein genes in animals and their genetic diversity in humans. Nucleic Acids Res 2014; 42 (Database issue):D437-D443.